Sage Therapeutics to Report First Quarter 2019 Financial Results on Thursday, May 2, 2019
April 18 2019 - 4:30PM
Business Wire
Sage Therapeutics (NASDAQ: SAGE), a clinical-stage
biopharmaceutical company developing novel medicines to treat
life-altering central nervous system (CNS) disorders, today
announced that the company will host a conference call and live
webcast on Thursday, May 2, 2019 at 8:00 A.M. ET to report its
first quarter 2019 financial results and to discuss recent business
updates.
The live webcast can be accessed on the investor page of Sage's
website at investor.sagerx.com. The conference call can be accessed
by dialing 1-866-450-8683 (toll-free domestic) or 1-281-542-4847
(international) and using the conference ID 5968036. A replay of
the webcast will be available on Sage's website approximately two
hours after the completion of the event and will be archived for up
to 30 days.
About Sage TherapeuticsSage Therapeutics is a
biopharmaceutical company committed to developing novel medicines
to transform the lives of patients with life-altering central
nervous system (CNS) disorders. Sage’s portfolio of novel compounds
targets critical receptor systems in the brain and includes the
first treatment specifically approved by the U.S. Food and Drug
Administration for postpartum depression as well as compounds being
developed as potential treatments for diseases such as major
depressive disorder, insomnia, bipolar disorder and essential
tremor. For more information, please visit www.sagerx.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190418005723/en/
Investor Contact:Maren Killackey,
617-949-4113maren.killackey@sagerx.com
Media Contact:Maureen L. Suda,
585-355-1134maureen.suda@sagerx.com
Sage Therapeutics (NASDAQ:SAGE)
Historical Stock Chart
From Mar 2024 to Apr 2024
Sage Therapeutics (NASDAQ:SAGE)
Historical Stock Chart
From Apr 2023 to Apr 2024